{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T15:39:34Z","timestamp":1770910774402,"version":"3.50.1"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,11,1]]},"DOI":"10.1093\/mmy\/myu060","type":"journal-article","created":{"date-parts":[[2014,10,7]],"date-time":"2014-10-07T00:38:31Z","timestamp":1412642311000},"page":"798-803","source":"Crossref","is-referenced-by-count":22,"title":["Efficacy of caspofungin, a 1,3-\u03b2-D-glucan synthase inhibitor, on Pneumocystis carinii pneumonia in rats"],"prefix":"10.1093","volume":"52","author":[{"given":"Peipei","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaohui","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,10,6]]},"reference":[{"key":"key\n\t\t\t\t20171012020603_bib1","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1086\/339548","article-title":"Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome","volume":"34","author":"Sepkowitz","year":"2002","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171012020603_bib2","doi-asserted-by":"crossref","first-page":"663","DOI":"10.7326\/0003-4819-100-5-663","article-title":"Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies","volume":"100","author":"Kovacs","year":"1984","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20171012020603_bib3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/15412550701817656","article-title":"Pneumocystis: a novel pathogen in chronic obstructive pulmonary disease?","volume":"5","author":"Morris","year":"2008","journal-title":"COPD"},{"key":"key\n\t\t\t\t20171012020603_bib4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/art.24283","article-title":"Pneumocystis jiroveci pneumonia in patients with rheumatoid arthritis treated with infliximab: a retrospective review and case-control study of 21 patients","volume":"61","author":"Komano","year":"2009","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20171012020603_bib5","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s10620-006-9250-x","article-title":"Pneumocystis jiroveci (carinii) pneumonia after infliximab therapy: a review of 84 cases","volume":"52","author":"Kaur","year":"2007","journal-title":"Dig Dis Sci"},{"key":"key\n\t\t\t\t20171012020603_bib6","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1586\/eri.10.42","article-title":"Pneumocystis infection in humans: diagnosis and treatment","volume":"8","author":"Calderon","year":"2010","journal-title":"Expert Rev Anti Infect Ther"},{"key":"key\n\t\t\t\t20171012020603_bib7","doi-asserted-by":"crossref","first-page":"730","DOI":"10.4065\/74.7.730","article-title":"Trimethoprim-sulfamethoxazole","volume":"74","author":"Smilack","year":"1999","journal-title":"Mayo Clin Proc"},{"key":"key\n\t\t\t\t20171012020603_bib8","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1503\/cmaj.111152","article-title":"Considerations when prescribing trimethoprim-sulfamethoxazole","volume":"183","author":"Ho","year":"2011","journal-title":"CMAJ"},{"key":"key\n\t\t\t\t20171012020603_bib9","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1345\/aph.1D179","article-title":"Adverse reactions to trimethoprim\/sulfamethoxazole in AIDS","volume":"37","author":"Floris-Moore","year":"2003","journal-title":"Ann Pharmacother"},{"key":"key\n\t\t\t\t20171012020603_bib10","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMra032588","article-title":"Pneumocystis pneumonia","volume":"350","author":"Thomas","year":"2004","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171012020603_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-6968.2010.02007.x","article-title":"Sterol biosynthesis and sterol uptake in the fungal pathogen Pneumocystis carinii","volume":"311","author":"Joffrion","year":"2010","journal-title":"FEMS Microbiol Lett"},{"key":"key\n\t\t\t\t20171012020603_bib12","doi-asserted-by":"crossref","first-page":"40628","DOI":"10.1074\/jbc.M002103200","article-title":"Cell wall assembly by Pneumocystis carinii. Evidence for a unique gsc-1 subunit mediating beta-1,3-glucan deposition","volume":"275","author":"Kottom","year":"2000","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20171012020603_bib13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/11585270-000000000-00000","article-title":"Echinocandin antifungal drugs in fungal infections: a comparison","volume":"71","author":"Chen","year":"2011","journal-title":"Drugs"},{"key":"key\n\t\t\t\t20171012020603_bib14","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1550-7408.1998.tb04545.x","article-title":"Cell wall antigens of Pneumocystis carinii trophozoites and cysts: purification and carbohydrate analysis of these glycoproteins","volume":"45","author":"De Stefano","year":"1998","journal-title":"J Eukaryot Microbiol"},{"key":"key\n\t\t\t\t20171012020603_bib15","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1093\/jac\/dkq081","article-title":"Echinocandin pharmacodynamics: review and clinical implications","volume":"65","author":"Pound","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171012020603_bib16","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1345\/aph.1M237","article-title":"Echinocandins: the newest class of antifungals","volume":"43","author":"Sucher","year":"2009","journal-title":"Ann Pharmacother"},{"key":"key\n\t\t\t\t20171012020603_bib17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1055\/s-2006-933433","article-title":"Combined trimethoprim and caspofungin treatment for severe Pneumocystis jiroveci pneumonia in a five year old boy with acute lymphoblastic leukemia","volume":"218","author":"Beltz","year":"2006","journal-title":"Klin Padiatr"},{"key":"key\n\t\t\t\t20171012020603_bib18","first-page":"463","article-title":"The treatment of Pneumocystis carinii pneumonia with caspofungin in elderly patients: a case report and literature review","volume":"29","author":"Zhang","year":"2006","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"key\n\t\t\t\t20171012020603_bib19","first-page":"996","article-title":"Caspofungin in salvage treatment of severe pneumocystis pneumonia: case report and literature review","volume":"122","author":"Mu","year":"2009","journal-title":"Chin Med J (Engl)"},{"key":"key\n\t\t\t\t20171012020603_bib20","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1086\/508282","article-title":"Progression of Pneumocystis jirovecii pneumonia in patients receiving echinocandin therapy","volume":"43","author":"Kamboj","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171012020603_bib21","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s10096-005-0065-z","article-title":"Caspofungin treatment of Pneumocystis pneumonia during conditioning for bone marrow transplantation","volume":"25","author":"Annaloro","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"Suppl","key":"key\n\t\t\t\t20171012020603_bib22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1439-0507.2008.01530.x","article-title":"Pneumocystis jiroveci pneumonia in a patient with Wegener's granulomatosis treated efficiently with caspofungin","volume":"51","author":"Hof","year":"2008","journal-title":"Mycoses"},{"key":"key\n\t\t\t\t20171012020603_bib23","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/nep.12133","article-title":"Combination of caspofungin and low-dose trimethoprim\/sulfamethoxazole for the treatment of severe Pneumocystis jirovecii pneumonia in renal transplant recipients","volume":"18","author":"Tu","year":"2013","journal-title":"Nephrology (Carlton)"},{"key":"key\n\t\t\t\t20171012020603_bib24","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/01.tp.0000280546.91617.6c","article-title":"Efficacy of caspofungin addition to trimethoprim-sulfamethoxazole treatment for severe Pneumocystis pneumonia in solid organ transplant recipients","volume":"84","author":"Utili","year":"2007","journal-title":"Transplantation"},{"key":"key\n\t\t\t\t20171012020603_bib25","doi-asserted-by":"crossref","first-page":"e8524","DOI":"10.1371\/journal.pone.0008524","article-title":"Echinocandin treatment of pneumocystis pneumonia in rodent models depletes cysts leaving trophic burdens that cannot transmit the infection","volume":"5","author":"Cushion","year":"2010","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20171012020603_bib26","doi-asserted-by":"crossref","first-page":"e70619","DOI":"10.1371\/journal.pone.0070619","article-title":"Therapeutic potential of caspofungin combined with trimethoprim-sulfamethoxazole for pneumocystis pneumonia: a pilot study in mice","volume":"8","author":"Lobo","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20171012020603_bib27","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.1073\/pnas.87.15.5950","article-title":"Treatment of Pneumocystis carinii pneumonia with 1,3-beta-glucan synthesis inhibitors","volume":"87","author":"Schmatz","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20171012020603_bib28","first-page":"151S","article-title":"Treatment and prevention of Pneumocystis carinii pneumonia and further elucidation of the P. carinii life cycle with 1,3-beta-glucan synthesis inhibitor L-671,329","volume":"38","author":"Schmatz","year":"1991","journal-title":"J Protozool"},{"key":"key\n\t\t\t\t20171012020603_bib29","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1128\/AAC.42.8.1985","article-title":"Efficacy of MK-991 (L-743,872), a semisynthetic pneumocandin, in murine models of Pneumocystis carinii","volume":"42","author":"Powles","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171012020603_bib30","first-page":"123","article-title":"Management of Pneumocystis jirovecii pneumonia in HIV infected patients: current options, challenges and future directions","volume":"2","author":"Castro","year":"2010","journal-title":"HIV AIDS (Auckl)"}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mmy\/article-pdf\/52\/8\/798\/9349181\/myu060.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T18:26:52Z","timestamp":1565893612000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/mmy\/article\/52\/8\/798\/2829990\/Efficacy-of-caspofungin-a-13\u03b2Dglucan-synthase"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,6]]},"references-count":30,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2014,10,6]]},"published-print":{"date-parts":[[2014,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myu060","relation":{},"ISSN":["1460-2709","1369-3786"],"issn-type":[{"value":"1460-2709","type":"electronic"},{"value":"1369-3786","type":"print"}],"subject":[],"published-other":{"date-parts":[[2014,11]]},"published":{"date-parts":[[2014,10,6]]}}}